AMH testing
Did you know
1in 6 couples world wide experience some form of infertility.
Polycysti covary syndrome(PCOS) affects 5-10% of women of reproductive age.
In 30 years, the success rate of IVF has increased from 10% to above 30%.
At birth, women have about 2 million eggs in their ovaries. This is the entire supply of eggs for a lifetime.
As women age, the number of eggs suitable for a viable pregnancy decrease in quality and quantity.
Anti-Mullerian Hormone - AMH
AMH plays a fundamental role in the regression of Mullerian ducts in male embryo and in its absence, Mullerian ducts develop into female inner reproductive organs. In females, it is secreted by the granulosa cells of pre-antral and small antral ovarian follicles. AMH regulates follicle recruitment and growth of small ovarian follicles while preventing exhaustion of follicular pool.
Serum levels of AMH correlate with the number of primordial follicles in an ovary (true ovarian reserve). The determination of AMH is used for the assessment of the ovarian reserve in conjunction with other clinical and laboratory findings.
Benefits of AMH testing
Anti-Müllerian hormone (AMH) is a very important and accurate marker of ovarian reserve, which could indicate remaining quantity of eggs and the remaining fertile time for a woman
AMH can be used for personalization of infertility management (IVF/ART), such as assessment of ovarian reserve for infertility investigations, and help to select the best stimulation protocol.
AMH is a hormone produced by the growing ovarian follicles. Blood levels of this hormone are used to measure the size of the growing pool of eggs.
This can empower couples to make decisions about the right time to get pregnant naturally or to consider treatment .
AMH can be used for the detection of ovarian dysfunction, such as PCOS, Premature ovarian failure, etc.
The use of AMH rather than Follicle Stimulating Hormone (FSH) or Luteinizing Hormone (LH) provides direct, and more accurate assessment of ovulation.
DiaSino AMH features
Ready to use reagents across whole kit
One-step sandwich principle, only 80 minutes assay time
Low limit of detection (LoD) up to 0.02 ng/mL
Wide measuring range between 0 -25 ng/mL
Clinical correlation to Roche Elecsys AMH ECLIA up to r ≥ 99%
Developed and launched in 2017
~1,200,000 AMH ELISA tests shipped till 12/2020
Reliable predictor of ovarian function and infertility in women
© 2032 DiaSino Laboratories Co., Ltd. All Rights Reserved.